{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T10:26:46Z","timestamp":1758450406067,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Medical University of Bialystok","award":["123-50722L"],"award-info":[{"award-number":["123-50722L"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.metabol.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T06:52:02Z","timestamp":1455691922000},"page":"804-811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Serum anti-M\u00fcllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus"],"prefix":"10.1016","volume":"65","author":[{"given":"Agnieszka","family":"\u0141ebkowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Adamska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Karczewska-Kupczewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Niko\u0142ajuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Otziomek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6241-8283","authenticated-orcid":false,"given":"Robert","family":"Milewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"G\u00f3rska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir","family":"Wo\u0142czy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Kowalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.metabol.2016.02.005_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Group REA-SPCW","year":"2004","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.metabol.2016.02.005_bb0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.metabol.2015.01.005","article-title":"Adolescent oligomenorrhea (age 14-19) tracks into the third decade of life (age 20-28) and predicts increased cardiovascular risk factors and metabolic syndrome","volume":"64","author":"Glueck","year":"2015","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.metabol.2016.02.005_bb0015","first-page":"4182","article-title":"High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus","volume":"85","author":"Escobar-Morreale","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.metabol.2016.02.005_bb0020","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1210\/jc.2006-0108","article-title":"Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus","volume":"91","author":"Codner","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2016.02.005_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jc.2013-2669","article-title":"No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus","volume":"99","author":"Amato","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.metabol.2016.02.005_bb0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/jdi.12040","article-title":"Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus","volume":"4","author":"Miyoshi","year":"2013","journal-title":"J Diabetes Investig"},{"issue":"2","key":"10.1016\/j.metabol.2016.02.005_bb0035","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jcem.82.2.3727","article-title":"The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome","volume":"82","author":"Fulghesu","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2016.02.005_bb0040","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/jcem-61-4-728","article-title":"Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary","volume":"61","author":"Poretsky","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.metabol.2016.02.005_bb0045","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1210\/jc.2007-1252","article-title":"Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus","volume":"92","author":"Codner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2016.02.005_bb0050","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1210\/jc.2006-2641","article-title":"Clinical review: hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus","volume":"92","author":"Codner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.metabol.2016.02.005_bb0055","first-page":"121","article-title":"Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy","volume":"64","author":"Zachurzok","year":"2013","journal-title":"Endokrynol Pol"},{"issue":"5","key":"10.1016\/j.metabol.2016.02.005_bb0060","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","article-title":"Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells","volume":"96","author":"Pellatt","year":"2011","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.metabol.2016.02.005_bb0065","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.metabol.2016.02.005_bb0070","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/humrep\/deq019","article-title":"Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles","volume":"25","author":"Andersen","year":"2010","journal-title":"Hum Reprod"},{"issue":"11","key":"10.1016\/j.metabol.2016.02.005_bb0075","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.metabol.2016.02.005_bb0080","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.metabol.2016.02.005_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.2010.03887.x","article-title":"Elevated anti-M\u00fcllerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus","volume":"74","author":"Codner","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.metabol.2016.02.005_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jcu.1870090504","article-title":"Medical implications of ultrasonically detected polycystic ovaries","volume":"9","author":"Swanson","year":"1981","journal-title":"J Clin Ultrasound"},{"issue":"10","key":"10.1016\/j.metabol.2016.02.005_bb0095","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.metabol.2016.02.005_bb0100","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2016.02.005_bb0105","first-page":"227","article-title":"Anti-mullerian hormone level and polycystic ovarian syndrome diagnosis","volume":"13","author":"Zadehmodarres","year":"2015","journal-title":"Iran J Reprod Med"},{"issue":"5","key":"10.1016\/j.metabol.2016.02.005_bb0110","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.fertnstert.2008.08.110","article-title":"Variations in serum m\u00fcllerian inhibiting substance between white, black, and Hispanic women","volume":"92","author":"Seifer","year":"2009","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.metabol.2016.02.005_bb0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts","volume":"25","author":"van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.metabol.2016.02.005_bb0120","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.rbmo.2012.09.001","article-title":"Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception","volume":"25","author":"Bentzen","year":"2012","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.metabol.2016.02.005_bb0125","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.fertnstert.2009.07.1676","article-title":"Longitudinal assessment of antim\u00fcllerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin","volume":"93","author":"Nelson","year":"2010","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.metabol.2016.02.005_bb0130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/molehr\/gat024","article-title":"Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection","volume":"19","author":"Jeppesen","year":"2013","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"10.1016\/j.metabol.2016.02.005_bb0135","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.metabol.2016.02.005_bb0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.fertnstert.2014.10.033","article-title":"Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antim\u00fcllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study","volume":"103","author":"Bhide","year":"2015","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.metabol.2016.02.005_bb0145","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/humrep\/dev131","article-title":"The phenotypic diversity in per-follicle anti-M\u00fcllerian hormone production in polycystic ovary syndrome","volume":"30","author":"Alebi\u0107","year":"2015","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.metabol.2016.02.005_bb0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antim\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.metabol.2016.02.005_bb0155","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1210\/endo-123-2-733","article-title":"Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells","volume":"123","author":"Cara","year":"1988","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.metabol.2016.02.005_bb0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM198607243150402","article-title":"Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes","volume":"315","author":"Amiel","year":"1986","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.metabol.2016.02.005_bb0165","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/humupd\/dms024","article-title":"Female reproduction and type 1 diabetes: from mechanisms to clinical findings","volume":"18","author":"Codner","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"7","key":"10.1016\/j.metabol.2016.02.005_bb0170","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/humrep\/dep074","article-title":"Anti-M\u00fcllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome","volume":"24","author":"Carlsen","year":"2009","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.metabol.2016.02.005_bb0175","first-page":"1158","article-title":"Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries","volume":"79","author":"Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.metabol.2016.02.005_bb0180","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2337\/diacare.24.7.1297","article-title":"Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients","volume":"24","author":"Rold\u00e1n","year":"2001","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.metabol.2016.02.005_bb0185","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.fertnstert.2011.09.023","article-title":"Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index","volume":"96","author":"Bizzarri","year":"2011","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.metabol.2016.02.005_bb0190","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.mehy.2011.07.005","article-title":"Serum anti-M\u00fcllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels","volume":"77","author":"Panidis","year":"2011","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.metabol.2016.02.005_bb0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(01)02944-2","article-title":"Relationship between serum m\u00fcllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women","volume":"77","author":"Cook","year":"2002","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.metabol.2016.02.005_bb0200","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejogrb.2011.06.006","article-title":"Is the plasma anti-M\u00fcllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?","volume":"158","author":"Ska\u0142ba","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.metabol.2016.02.005_bb0205","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2016.02.005_bb0210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/cen.12687","article-title":"Circulating anti-M\u00fcllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome","volume":"83","author":"Olszanecka-Glinianowicz","year":"2015","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516000366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516000366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:12:51Z","timestamp":1758427971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049516000366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0026049516000366"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2016.02.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum anti-M\u00fcllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}